Page 71 - Read Online

41. Ghosh M, Brancato SJ, Agarwal PK, Apolo AB. Targeted The aggressiveness of urothelial carcinoma depends to a large
therapies in urothelial carcinoma. Curr Opin Oncol extent on lymphovascular invasion --the prognostic contribution
2014;26:305-20. of related molecular markers. Histopathology 2009;55:514-24.
42. von Hardenberg J, Martini T, Knauer A, Strobel P, Becker A, 55. Chaudhary R, Bromley M, Clarke NW, Betts CD, Barnard RJ,
Herrmann E, Schubert C, Steidler A, Bolenz C. Expression Ryder WD, Kumar S. Prognostic relevance of micro-vessel
and predictive value of lymph-specifi c markers in urothelial density in cancer of the urinary bladder. Anticancer Res
carcinoma of the bladder. Urol Oncol 2014;32:54.e9-17. 1999;19:3479-84.
43. Zu X, Tang Z, Li Y, Gao N, Ding J, Qi L. Vascular endothelial 56. Shariat SF, Youssef RF, Gupta A, Chade DC, Karakiewicz PI,
growth factor-C expression in bladder transitional cell cancer Isbarn H, Jeldres C, Sagalowsky AI, Ashfaq R, Lotan Y.
and its relationship to lymph node metastasis. BJU Int Association of angiogenesis related markers with bladder
2006;98:1090-3. cancer outcomes and other molecular markers. J Urol
44. Fernandez-Gomez J, Solsona E, Unda M, Martinez-Pineiro L, 2010;183:1744-50.
Gonzalez M, Hernandez R, Madero R, Ojea A, Pertusa C, 57. Rink M, Cha EK, Green D, Hansen J, Robinson BD,
Rodriguez-Molina J, Camacho JE, Isorna S, Rabadan M, Lotan Y, Sagalowsky AI, Chun FK, Karakiewicz PI, Fisch M,
Astobieta A, Montesinos M, Muntanola P, Gimeno A, Blas M, Scherr DS, Shariat SF. Biomolecular predictors of urothelial
Martinez-Pineiro JA. Prognostic factors in patients with cancer behavior and treatment outcomes. Curr Urol Rep
non-muscle-invasive bladder cancer treated with bacillus 2012;13:122-35.
Calmette-Guerin: multivariate analysis of data from four 58. Horikawa Y, Kumazawa T, Narita S, Inoue T, Yuasa T,
randomized CUETO trials. Eur Urol 2008;53:992-1001. Matsuura S, Nanjo H, Satoh S, Tsuchiya N, Habuchi T.
45. Zhou M, He L, Zu X, Zhang H, Zeng H, Qi L. Lymphatic Lymphatic invasion is a prognostic factor for bladder
vessel density as a predictor of lymph node metastasis and cancer treated with radical cystectomy. Int J Clin Oncol
its relationship with prognosis in urothelial carcinoma of the 2007;12:131-6.
bladder. BJU Int 2011;107:1930-5. 59. Ma Y, Hou Y, Liu B, Li X, Yang S, Ma J. Intratumoral
46. Yang H, Kim C, Kim MJ, Schwendener RA, Alitalo K, lymphatics and lymphatic vessel invasion detected by D2-40
Heston W, Kim I, Kim WJ, Koh GY. Soluble vascular are essential for lymph node metastasis in bladder transitional
endothelial growth factor receptor-3 suppresses cell carcinoma. Anat Rec (Hoboken) 2010;293:1847-54.
lymphangiogenesis and lymphatic metastasis in bladder cancer. 60. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB,
Mol Cancer 2011;10:36. Boucher Y, Choi NC, Mathisen D, Wain J, Mark EJ, Munn LL,
47. Zhang HH, Qi F, Shi YR, Miao JG, Zhou M, He W, Chen MF, Jain RK. Lymphatic metastasis in the absence of functional
Li Y, Zu XB, Qi L. RNA interference-mediated vascular intratumor lymphatics. Science 2002;296:1883-6.
endothelial growth factor-C reduction suppresses malignant 61. Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E,
progression and enhances mitomycin C sensitivity of bladder Jain RK. Pathology: cancer cells compress intratumour
cancer T24 cells. Cancer Biother Radiopharm 2012;27:291-8. vessels. Nature 2004;427:695.
48. Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, 62. Bolenz C, Auer M, Strobel P, Heinzelbecker J, Schubert C,
Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Trojan L. The lymphatic system in clinically localized
Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, urothelial carcinoma of the bladder: morphologic characteristics
Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, and predictive value. Urol Oncol 2013;31:1606-14.
Lotan Y, Marberger MJ, Fradet Y. International validation of 63. De Bock K, Cauwenberghs S, Carmeliet P. Vessel
the prognostic value of lymphovascular invasion in patients abnormalization: Another hallmark of cancer? Molecular
treated with radical cystectomy. BJU Int 2010;105:1402-12. mechanisms and therapeutic implications. Curr Opin Genet
49. von Rundstedt FC, Mata DA, Groshen S, Stein JP, Skinner DG, Dev 2011;21:73-9.
Stadler WM, Cote RJ, Kryvenko ON, Godoy G, Lerner SP. 64. Bambury RM, Rosenberg JE. Advanced urothelial carcinoma:
Signifi cance of lymphovascular invasion in organ-confi ned, overcoming treatment resistance through novel treatment
node-negative urothelial cancer of the bladder: data from approaches. Front Pharmacol 2013;4:3.
the prospective p53-MVAC trial. BJU Int 2014;doi: 10.1111/ 65. Carmeliet P, Jain RK. Molecular mechanisms and clinical
bju.12997. applications of angiogenesis. Nature 2011;473:298-307.
50. Martin-Doyle W, Leow JJ, Orsola A, Chang SL, Bellmunt J. 66. Videira PA, Piteira AR, Cabral MG, Martins C, Correia M,
Improving selection criteria for early cystectomy in high-grade Severino P, Gouveia H, Carrascal M, Almeida JF,
t1 bladder cancer: a meta-analysis of 15,215 patients. J Clin Trindade H, Santos LL. Effects of bevacizumab on autocrine
Oncol 2015;33:643-50. VEGF stimulation in bladder cancer cell lines. Urol Int
51. Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wulfi ng C, 2011;86:95-101.
Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, 67. Humar R, Kiefer FN, Berns H, Resink TJ, Battegay EJ.
Wieland WF, Hofner T, Haferkamp A, Hohenfellner M, Hypoxia enhances vascular cell proliferation and angiogenesis
Muller SC, Strobel P, Trojan L. Lymphovascular invasion is in vitro via rapamycin (mTOR)-dependent signaling. FASEB J
an independent predictor of oncological outcomes in patients 2002;16:771-80.
with lymph node-negative urothelial bladder cancer treated 68. Watanabe R, Wei L, Huang J. mTOR signaling, function,
by radical cystectomy: a multicentre validation trial. BJU Int novel inhibitors, and therapeutic targets. J Nucl Med
2010;106:493-9. 2011;52:497-500.
52. Algaba F. Lymphovascular invasion as a prognostic tool for 69. Fechner G, Classen K, Schmidt D, Hauser S, Muller SC.
advanced bladder cancer. Curr Opin Urol 2006;16:367-71. Rapamycin inhibits in vitro growth and release of angiogenetic
53. Mazzucchelli R, Cheng L, Lopez-Beltran A, Scarpelli M, factors in human bladder cancer. Urology 2009;73:665-8.
Montironi R. Clinicopathological signifi cance of 70. Seront E, Rottey S, Sautois B, Kerger J, D’Hondt LA,
lymphovascular invasion in urothelial carcinoma. Anal Quant Verschaeve V, Canon JL, Dopchie C, Vandenbulcke JM,
Cytol Histol 2012;34:173-9. Whenham N, Goeminne JC, Clausse M, Verhoeven D,
54. Afonso J, Santos LL, Amaro T, Lobo F, Longatto-Filho A. Glorieux P, Branders S, Dupont P, Schoonjans J, Feron O,

64 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 2 ¦ July 15, 2015 ¦